Agents Classified by the IARC Monographs, Volumes 1–107
026148-68-5 A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) 2B
025732-74-5 Acepyrene (3,4-dihydrocyclopenta[cd]pyrene) 3
000075-07-0 Acetaldehyde associated with consumption of alcoholic
000103-90-2 Acetaminophen (see Paracetamol)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
Acrylonitrile-butadiene-styrene copolymers
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
003688-53-7 AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide] 2B
Agents Classified by the IARC Monographs, Volumes 1–107
000097-56-3 ortho-Aminoazotoluene
000150-13-0 para-Aminobenzoic acid
000081-49-2 1-Amino-2,4-dibromoanthraquinone
000082-28-0 1-Amino-2-methylanthraquinone
000712-68-5 2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole
(NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data)
000523-50-2 Angelicin plus ultraviolet A radiation
(NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data)
000313-67-7 Aristolochic acid, plants containing
Agents Classified by the IARC Monographs, Volumes 1–107
007440-38-2 Arsenic and inorganic arsenic compounds
064436-13-1 Arsenobetaine and other organic arsenic compounds that
Art glass, glass containers and pressed ware
001332-21-4 Asbestos (all forms, including actinolite, amosite,
anthophyllite, chrysotile, crocidolite, tremolite)
(NB: Mineral substances (e.g. talc or vermiculite) that
contain asbestos should also be regarded as
(NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data)
012174-11-7 Attapulgite (see Palygorskite)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
(NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data)
000202-94-8 11H-Benz[bc]aceanthrylene 3
(NB: Overall evaluation upgraded to Group 2B with supporting mechanistic and other relevant data)
000211-91-6 Benz[l]aceanthrylene 3
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data)
000203-33-8 Benzo[a]fluoranthene 3
000205-99-2 Benzo[b]fluoranthene 2B
000203-12-3 Benzo[ghi]fluoranthene 3
000205-82-3 Benzo[j]fluoranthene 2B
000207-08-9 Benzo[k]fluoranthene 2B
000239-35-0 Benzo[b]naphtho[2,1-d]thiophene 3
(NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data)
(NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data)
000105-11-3 para-Benzoquinone dioxime
007440-41-7 Beryllium and beryllium compounds
Agents Classified by the IARC Monographs, Volumes 1–107
Biomass fuel (primarily wood), indoor emissions from
002168-68-5 Bis(1-aziridinyl)morpholinophosphine sulfide
003296-90-0 2,2-Bis(bromomethyl)propane-1,3-diol
000494-03-1 N,N-Bis(2-chloroethyl)-2-naphthylamine (see
000154-93-8 Bischloroethyl nitrosourea (BCNU)
013483-18-6 1,2-Bis(chloromethoxy)ethane
056894-91-8 1,4-Bis(chloromethoxymethyl)benzene
000542-88-1 Bis(chloromethyl)ether; chloromethyl methyl ether
000108-60-1 Bis(2-chloro-1-methylethyl)ether
002386-90-5 Bis(2,3-epoxycyclopentyl)ether
000117-81-7 Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl)
001675-54-3 Bisphenol A diglycidyl ether (Araldite)
008052-42-4 Bitumens, extracts of steam-refined and air-refined;
steam-refined, cracking-residue and air-refined bitumens (see Bitumens, occupational exposures)
Bitumens, occupational exposure to hard bitumens and
their emissions during mastic asphalt work
064742-93-4 Bitumens, occupational exposure to oxidized bitumens
008052-42-4 Bitumens, occupational exposure to straight-run bitumens
(NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data)
Boot and shoe manufacture and repair (see Leather dust,
003844-45-9 Brilliant Blue FCF, disodium salt
Agents Classified by the IARC Monographs, Volumes 1–107
000055-98-1 1,4-Butanediol dimethanesulfonate (see Busulfan)
057018-52-7 1-tert-Butoxypropan-2-ol 3
025013-16-5 Butylated hydroxyanisole (BHA)
000128-37-0 Butylated hydroxytoluene (BHT)
007440-43-9 Cadmium and cadmium compounds
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
053973-98-1 Carrageenan, degraded (Poligeenan)
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
Chlorinated paraffins of average carbon chain length C12
and average degree of chlorination approximately 60%
000098-87-3 alpha-Chlorinated toluenes (benzal chloride,
benzotrichloride, benzyl chloride) and benzoyl chloride (combined exposures)
000106-47-8 para-Chloroaniline 2B
077439-76-0 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone 2B
013010-47-4 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
013909-09-6 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea
000107-30-2 Chloromethyl methyl ether (see Bis(chloromethyl)ether;
Agents Classified by the IARC Monographs, Volumes 1–107
005131-60-2 4-Chloro-meta-phenylenediamine 3
000095-83-0 4-Chloro-ortho-phenylenediamine 2B
000095-69-2 4-Chloro-ortho-toluidine 2A
000095-79-4 5-Chloro-ortho-toluidine 3
000075-88-7 2-Chloro-1,1,1-trifluoroethane
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
001937-37-7 CI Direct Black 38 (see Benzidine, dyes metabolized to)
002602-46-2 CI Direct Blue 6 (see Benzidine, dyes metabolized to)
016071-86-6 CI Direct Brown 95 (see Benzidine, dyes metabolized to)
059865-13-3 Ciclosporin (see Cyclosporine)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
Agents Classified by the IARC Monographs, Volumes 1–107 Clonorchis sinensis (infection with)
Coal, indoor emissions from household combustion of
008007-45-2 Coal tars (see Coal-tar distillation)
007440-48-4 Cobalt metal with tungsten carbide
007440-48-4 Cobalt metal without tungsten carbide
010026-24-1 Cobalt sulfate and other soluble cobalt(II) salts
068603-42-9 Coconut oil diethanolamine condensate
(NB: There is some evidence of an inverse relationship between coffee drinking and cancer of the large bowel; coffee drinking could not be classified as to its carcinogenicity to other organs)
Continuous glass filament (see Glass filament)
000102-50-1 meta-Cresidine
000139-05-9 Cyclamates (sodium cyclamate)
000202-98-2 4H-Cyclopenta[def]chrysene 3
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
Agents Classified by the IARC Monographs, Volumes 1–107
007099-43-6 5,6-Cyclopenteno-1,2-benzanthracene
000117-10-2 Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) 2B
000050-29-3 DDT (4,4'-Dichlorodiphenyltrichloroethane)
000613-35-4 N,N'-Diacetylbenzidine 2B
000226-36-8 Dibenz[a,h]acridine 2B
(NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
(NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data)
000215-58-7 Dibenz[a,c]anthracene 3
000053-70-3 Dibenz[a,h]anthracene
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000224-41-9 Dibenz[a,j]anthracene 3
000194-59-2 7H-Dibenzo[c,g]carbazole 2B
000262-12-4 Dibenzo-para-dioxin 3
Agents Classified by the IARC Monographs, Volumes 1–107
005385-75-1 Dibenzo[a,e]fluoranthene 3
000207-83-0 13H-Dibenzo[a,g]fluorene 3
000192-47-2 Dibenzo[h,rst]pentaphene 3
000189-64-0 Dibenzo[a,h]pyrene 2B
000189-55-9 Dibenzo[a,i]pyrene 2B
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000541-73-1 meta-Dichlorobenzene 3
000095-50-1 ortho-Dichlorobenzene 3
000106-46-7 para-Dichlorobenzene 2B
000110-57-6 trans-1,4-Dichlorobutene
028434-86-8 3,3'-Dichloro-4,4'-diaminodiphenyl ether
000075-09-2 Dichloromethane (Methylene chloride)
000609-20-1 2,6-Dichloro-para-phenylenediamine
000542-75-6 1,3-Dichloropropene (technical-grade)
001464-53-5 1,2:3,4-Diepoxybutane (see Monographs on 1,3-
Diesel engine exhaust (see Engine exhaust, diesel)
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000105-55-5 N,N'-Diethylthiourea 3
000794-93-4 Dihydroxymethylfuratrizine (see also Panfuran S)
000119-90-4 3,3'-Dimethoxybenzidine (ortho-Dianisidine)
000091-93-0 3,3'-Dimethoxybenzidine-4,4'-diisocyanate
000060-11-7 para-Dimethylaminoazobenzene
000140-56-7 para-Dimethylaminoazobenzenediazo sodium sulfonate
025962-77-0 trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-
022975-76-4 4,4'-Dimethylangelicin plus ultraviolet A radiation
004063-41-6 4,5'-Dimethylangelicin plus ultraviolet A radiation
000087-62-7 2,6-Dimethylaniline (2,6-Xylidine)
000121-69-7 N,N-Dimethylaniline 3
000119-93-7 3,3'-Dimethylbenzidine (ortho-Tolidine)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000101-25-7 Dinitrosopentamethylenetetramine
Dry cleaning (occupational exposures in)
Dyes metabolized to benzidine (see Benzidine, dyes
Electric fields, extremely low-frequency
(NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
(NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data)
000141-37-7 3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-
Agents Classified by the IARC Monographs, Volumes 1–107
002443-39-2 cis-9,10-Epoxystearic acid
Estrogen-progestogen menopausal therapy (combined)
Estrogen-progestogen oral contraceptives (combined)
(NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary)
000064-17-5 Ethanol in alcoholic beverages
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
(NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data)
(NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data)
000759-73-9 N-Ethyl-N-nitrosourea
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
(NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data)
033419-42-0 Etoposide in combination with cisplatin and bleomycin
Agents Classified by the IARC Monographs, Volumes 1–107
Firefighter (occupational exposure as a)
Fission products, including strontium-90
Flat-glass and specialty glass (manufacture of)
016984-48-8 Fluorides (inorganic, used in drinking-water)
Foreign bodies (see Surgical implants and other foreign
003570-75-0 2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole
Furniture and cabinet making (see Wood dust)
Fusarium graminearum, F. culmorum,and F. crookwellense, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X)
116355-83-0 Fusarium moniliforme, toxins derived from (fumonisin B1,
Fusarium sporotrichioides, toxins derived from (T-2 toxin)
001303-00-0 Gallium arsenide (see Arsenic and inorganic arsenic
Gamma-Radiation (see X- and Gamma-Radiation)
(NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data)
Gasoline engine exhaust (see Engine exhaust, gasoline)
Agents Classified by the IARC Monographs, Volumes 1–107
067730-11-4 Glu-P-1 (2-Amino-6-methyldipyrido[1,2-a:3',2'-
067730-10-3 Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
Hair colouring products (personal use of)
Hairdresser or barber (occupational exposure as a)
Helicobacter pylori (infection with)
Hepatitis B virus (chronic infection with)
Hepatitis C virus (chronic infection with)
Household combustion of biomass fuel (see Biomass
fuel, indoor emissions from household combustion of)
Agents Classified by the IARC Monographs, Volumes 1–107
Household combustion of coal (see Coal, indoor
Human herpesvirus type 4 (see Epstein-Barr virus)
Human herpesvirus type 8 (see Kaposi sarcoma
Human immunodeficiency virus type 1 (infection with)
Human immunodeficiency virus type 2 (infection with)
Human papillomavirus genus beta (except types 5 and 8)
Human papillomavirus types 5 and 8 (in patients with
Human papillomavirus types 16, 18, 31, 33, 35, 39, 45,
51, 52, 56, 58, 59 (NB: The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer)
Human papillomavirus types 26, 53, 66, 67, 70, 73, 82
Human papillomavirus types 30, 34, 69, 85, 97
(NB: Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1)
Human T-cell lymphotropic virus type II
000193-39-5 Indeno[1,2,3-cd]pyrene 2B
(NB: Overall evaluation upgraded to Group 2A)
Agents Classified by the IARC Monographs, Volumes 1–107
Involuntary smoking (see Tobacco smoke, second-hand)
010043-66-0 Iodine-131 (see Radioiodines)
076180-96-6 IQ (2-Amino-3-methylimidazo[4,5-f]quinoline)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
Iron and steel founding (occupational exposure during)
001338-16-5 Iron sorbitol-citric acid complex
000054-85-3 Isonicotinic acid hydrazide (Isoniazid)
Isopropyl alcohol manufacture using strong acids
(NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead.)
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data)
Lumber and sawmill industries (including logging)
Magnetic fields, extremely low-frequency
Malaria (caused by infection with Plasmodium falciparum
000551-74-6 Mannomustine dihydrochloride
068006-83-7 MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) 2B
077094-11-2 MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) 2B
077500-04-0 MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) 2B
(NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data)
007439-97-6 Mercury and inorganic mercury compounds
000298-81-7 Methoxsalen (8-methoxypsoralen) plus ultraviolet A
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
073459-03-7 5-Methylangelicin plus ultraviolet A radiation
000075-55-8 2-Methylaziridine (Propyleneimine)
001634-04-4 Methyl tert-butyl ether
000099-80-9 N-Methyl-N,4-dinitrosoaniline
000101-14-4 4,4'-Methylenebis(2-chloroaniline) (MOCA)
(NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data)
000838-88-0 4,4'-Methylene bis(2-methylaniline)
000101-68-8 4,4'-Methylenediphenyl diisocyanate
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000129-15-7 2-Methyl-1-nitroanthraquinone (uncertain purity)
Agents Classified by the IARC Monographs, Volumes 1–107
000070-25-7 N-Methyl-N´-nitro-N-nitrosoguanidine (MNNG)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000684-93-5 N-Methyl-N-nitrosourea
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000615-53-2 N-Methyl-N-nitrosourethane
090456-67-0 N-Methylolacrylamide 3
085878-63-3 7-Methylpyrido[3,4-c]psoralen 3
000101-61-1 Michler’s base [4,4 -methylenebis(N,N-dimethyl)-
000090-94-8 Michler’s ketone [4,4 -Bis(dimethylamino)-
Mineral oils, untreated or mildly treated
000096-24-2 3-Monochloro-1,2-propanediol 2B
MOPP and other combined chemotherapy including
003795-88-8 5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-2-
000505-60-2 Mustard gas (see Sulfur mustard)
Agents Classified by the IARC Monographs, Volumes 1–107
003173-72-6 1,5-Naphthalene diisocyanate
111189-32-3 Naphtho[1,2-b]fluoranthene 3
000203-20-3 Naphtho[2,1-a]fluoranthene 3
000193-09-9 Naphtho[2,3-e]pyrene 3
(NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data)
Nitrate or nitrite (ingested) under conditions that result in
000139-13-9 Nitrilotriacetic acid and its salts
000099-59-2 5-Nitro-ortho-anisidine 3
020268-51-3 7-Nitrobenz[a]anthracene 3
063041-90-7 6-Nitrobenzo[a]pyrene 3
Agents Classified by the IARC Monographs, Volumes 1–107
000555-84-0 1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone
000531-82-8 N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide
000126-85-2 Nitrogen mustard N-oxide
037620-20-5 N'-Nitrosoanabasine (NAB)
071267-22-6 N'-Nitrosoanatabine (NAT)
000924-16-3 N-Nitrosodi-n-butylamine
001116-54-7 N-Nitrosodiethanolamine
000055-18-5 N-Nitrosodiethylamine
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000062-75-9 N-Nitrosodimethylamine
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000086-30-6 N-Nitrosodiphenylamine
000156-10-5 para-Nitrosodiphenylamine
000621-64-7 N-Nitrosodi-n-propylamine
055557-02-3 N-Nitrosoguvacoline 3
030310-80-6 N-Nitrosohydroxyproline 3
085502-23-4 3-(N-Nitrosomethylamino)propionaldehyde 3
060153-49-3 3-(N-Nitrosomethylamino)propionitrile
010595-95-6 N-Nitrosomethylethylamine
004549-40-0 N-Nitrosomethylvinylamine
000059-89-2 N-Nitrosomorpholine
016543-55-8 N'-Nitrosonornicotine (NNN) and 4-(N-
Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data)
000100-75-4 N-Nitrosopiperidine
007519-36-0 N-NitrosoprolineAgents Classified by the IARC Monographs, Volumes 1–107
000930-55-2 N-Nitrosopyrrolidine
013256-22-9 N-Nitrososarcosine
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000099-55-8 5-Nitro-ortho-toluidine 3
Non-arsenical insecticides (occupational exposures in
Opisthorchis felineus (infection with)Opisthorchis viverrini (infection with)
Oral contraceptives, combined estrogen-progestogen
(see Estrogen-progestogen oral contraceptives)
000523-44-4 Orange I (see CI Acid Orange 20)
Paint manufacture (occupational exposure in)
012174-11-7 Palygorskite (Attapulgite) (long fibres, > 5 micrometres)
012174-11-7 Palygorskite (Attapulgite)(short fibres, < 5 micrometres)
000794-93-4 Panfuran S (containing dihydroxymethylfuratrizine)
Paving and roofing with coal-tar pitch (see Coal-tar pitch)
057465-28-8 3,4,5,3’,4’-Pentachlorobiphenyl (PCB-126)
(see Polychlorinated biphenyls, dioxin-like, with a TEF according to WHO)
Agents Classified by the IARC Monographs, Volumes 1–107
057117-31-4 2,3,4,7,8-Pentachlorodibenzofuran
(NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data)
000087-86-5 Pentachlorophenol (see Polychlorophenols)
Petroleum refining (occupational exposures in)
Pickled vegetables (traditional in Asia)
(NB: Overall evaluation upgraded to Group 1 with
supporting evidence from other relevant data)
Phenacetin, analgesic mixtures containing
000136-40-3 Phenazopyridine hydrochloride
000063-92-3 Phenoxybenzamine hydrochloride
000108-45-2 meta-Phenylenediamine 3
000106-50-3 para-Phenylenediamine 3
000135-88-6 N-Phenyl-2-naphthylamine 3
105650-23-5 PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) 2B
053973-98-1 Poligeenan (see Carrageenan, degraded)
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data, namely mechanistic similarity with polychlorinated biphenyls classified in Group 1)
Polychlorinated biphenyls, dioxin-like, with a Toxicity
Equivalency Factor (TEF) according to WHO (PCBs 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, 189) (NB: Overall evaluation upgraded to Group 1 with strong supporting evidence from other relevant data)
Polychlorinated dibenzo-para-dioxins (other than 2,3,7,8-
Polychlorophenols and their sodium salts (mixed
009016-87-9 Polymethylene polyphenyl isocyanate
023746-34-1 Potassium bis(2-hydroxyethyl)dithiocarbamate
Printing processes (occupational exposures in)
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
085878-62-2 Pyrido[3,4-c]psoralen 3
000082-68-8 Quintozene (Pentachloronitrobenzene)
Radiofrequency electromagnetic fields1 2B
Radionuclides, alpha-particle-emitting, internally
deposited (NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents)
Radionuclides, beta-particle-emitting, internally deposited
(NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents)
013233-32-4 Radium-224 and its decay products
013982-63-3 Radium-226 and its decay products
015262-20-1 Radium-228 and its decay products
010043-92-2 Radon-222 and its decay products
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data)
Schistosoma haematobium (infection with)
Schistosoma japonicum (infection with)
Schistosoma mansoni (infection with)
007782-49-2 Selenium and selenium compounds
013909-09-6 Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-
Shiftwork that involves circadian disruption
014808-60-7 Silica dust, crystalline, in the form of quartz or cristobalite
000148-18-5 Sodium diethyldithiocarbamate
000132-27-4 Sodium ortho-phenylphenate 2B
Agents Classified by the IARC Monographs, Volumes 1–107
Soot (as found in occupational exposure of chimney
Special-purpose fibres such as E-glass and '475' glass
007664-93-9 Strong-inorganic-acid mists containing sulfuric acid (see
010098-97-2 Strontium-90 (see Fission products)
009003-54-7 Styrene-acrylonitrile copolymers
009003-55-8 Styrene-butadiene copolymers
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000127-69-5 Sulfafurazole (Sulfisoxazole)
(NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data)
Sunlamps and sunbeds (see Ultraviolet-emitting tanning
Agents Classified by the IARC Monographs, Volumes 1–107
Surgical implants and other foreign bodies:
- Polymeric implants prepared as thin smooth film (with the exception of poly(glycolic acid)) - Metallic implants prepared as thin smooth films - Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium and 7% iron
Surgical implants and other foreign bodies:
- Organic polymeric materials (as a group) - Orthopaedic implants of complex composition - Cardiac pacemakers - Silicone breast implants - Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based and titanium-based alloys, stainless steel and depleted uranium - Dental materials - Ceramic implants
014807-96-6 Talc containing asbestiform fibres (see Asbestos)
014807-96-6 Talc not containing asbestos or asbestiform fibres
014807-96-6 Talc-based body powder (perineal use of)
(NB: There is also conclusive evidence that tamoxifen reduces the risk of contralateral breast cancer in breast cancer patients)
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
008001-50-1 Terpene polychlorinates (Strobane®)
015721-02-5 2,2',5,5'-Tetrachlorobenzidine
001746-01-6 2,3,7,8-Tetrachlorodibenzo-para-dioxin 1
000127-18-4 Tetrachloroethylene (Perchloroethylene)
Agents Classified by the IARC Monographs, Volumes 1–107
Tetrakis(hydroxymethyl)phosphonium salts
Textile manufacturing industry (work in)
007440-29-1 Thorium-232 and its decay products
008001-35-2 Toxaphene (Polychlorinated camphenes)
Toxins derived from certain Fusarium species (see
000817-09-4 Trichlormethine (Trimustine hydrochloride)
001954-28-5 Triethylene glycol diglycidyl ether
090370-29-9 4,4',6-Trimethylangelicin plus ultraviolet A radiation
Agents Classified by the IARC Monographs, Volumes 1–107
000068-76-8 Tris(aziridinyl)-para-benzoquinone (Triaziquone)
000545-55-1 Tris(1-aziridinyl)phosphine oxide
000051-18-3 2,4,6-Tris(1-aziridinyl)-s-triazine
000115-96-8 Tris(2-chloroethyl) phosphate
038571-73-2 1,2,3-Tris(chloromethoxy)propane
000126-72-7 Tris(2,3-dibromopropyl) phosphate
(NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data)
000057-39-6 Tris(2-methyl-1-aziridinyl)phosphine oxide
062450-06-0 Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole) 2B
062450-07-1 Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole) 2B
012070-12-1 Tungsten carbide with cobalt metal (see Cobalt metal
Ultraviolet radiation (wavelengths 100-400 nm,
(NB: (1) Overall evaluation upgraded to Group 2A
based on mechanistic and other relevant data; (2) For practical purposes, vinyl bromide should be considered to act similarly to the human carcinogen vinyl chloride.)
009003-22-9 Vinyl chloride-vinyl acetate copolymers
000106-87-6 4-Vinylcyclohexene diepoxide
Agents Classified by the IARC Monographs, Volumes 1–107
(NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride.)
009011-06-7 Vinylidene chloride-vinyl chloride copolymers
000088-12-0 N-Vinyl-2-pyrrolidone
(NB: Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders)
Wood smoke (see Biomass fuel, indoor emissions from
001318-02-1 Zeolites other than erionite (clinoptilolite,
phillipsite,mordenite, non-fibrous Japanese zeolite, synthetic zeolites)
1 Includes radiofrequency electromagnetic fields from wireless phones Last update: 10 April 2013
MAINE SCHOOL ASTHMA PLAN Child Name: To be completed by parent or school: Teacher:_____________________ Rm #:____ To be completed by parent: I authorize release of my child’s medical records and asthma plans from my child’s physician’s office to the school nurse. Parent or Guardian signature: _____________________________________________ Date:__________ Parent or
The Ne w E n g l a nd Jo u r n a l o f Me d ic i ne Editor’s note: Dr. Alderman has attended consulting 1. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001;344:3-10. 2. Graudal NA, Galloe AM, Garred P. Effects of sodium restric